Dario Crosetto, the founder of Crosetto Foundation
Dario Crosetto is the inventor of the 3D-CBS technology (Three-dimensional Complete Body Screening) for early cancer detection and winner of the Leonardo da Vinci Prize (June 2011) for the most efficient solution using particle detection for early cancer diagnosis, has 25 years’ experience in international collaboration in the field of high energy physics (HEP).
He participated on research teams and presented numerous seminars and articles at conferences at universities and at research labs in several countries: CERN, SSC, FERMILAB, BNL, SLAC, NEVIS, BERKLEY, DESY, University of Heidelberg, SACLAY, CPPM, Academia Sinica, etc.
He lectured at CERN School of Computing, published several books, over 100 articles and owns several patents. For 20 years he designed and improved apparatuses to detect high-energy physics (see the “peer-reviewed” article published in the scientific journal Nuclear Instruments and Methods in Physics Research, NIM -Vol. 436, pp. 341-385, 1999) and during the last years he focused in designing, simulating, building and testing components for his cancer screening 3D-CBS (Three-dimensional Complete Body Screening) device.
In 1992, in one month he presented his innovation at three international conferences at Computing in HEP, Annecy, France [September 21-25 1992. CERN-92-07. pp. 803-806.]; “Calorimetry in High Energy Physics”, Corpus Christi, TX. [September 29, October 2, 1992. World Scientific. pp. 553-566]; “IEEE Nuclear Science Symposium (NSS) and Medical Imaging (MIC)”, Orlando, FL [October 25-31. 1992. SSCL-Preprint-164].
During the same year, in this field he published also two “peer-reviewed” articles in the scientific journal Nuclear Instruments and Methods in Physics Research [NIM A311:49-56,1992 e NIM A315, (1992), 487-490]. On Dec. 14, 1993 he passed a major int’l scientific review at FERMIlab and emeritus scientists in the field wrote letters of recognition (see testimonials at www.crosettofoundation.org/uploads/167.pdf).
His innovation was adopted for use at GEM, half-billion dollar experiment at SSC in 1993 and LHCb at CERN in 1995 and included in their respective Technical Design Reports (TDRs), however, in both cases the U.S. DOE suddenly stopped funding both projects.
Since then, he focused in efficient, cost-effective particle detection application for Medical Imaging with the objective lower radiation dose to the patient, lower cost and provides an efficacious early cancer detection tool.
This post is also available in: Italian